(RTTNews) - As we head into the fourth quarter of 2021, here is a recap of what happened on the regulatory front this month that caught our attention. Samsung Bioepis' Byooviz became the first biosimilar for Lucentis to treat macular...

Paige Prostate was granted de novo marketing authorization from the FDA to aid in the primary diagnosis of prostate cancer. NEW YORK--(BUSINESS WIRE)--Paige, the global leader in AI-based diagnostic software in pathology, today announced...